Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07332975 · ClinicalTrials.gov registry record
ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC
A clinical trial, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 77
- Enrollment target
NCT07332975 is a clinical trial that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 77 participants.
The verdict
NCT07332975 is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 77 participants
- Enrollment target
Study Summary
This translational biomarker study will collect blood in patients Stage I triple negative breast cancer at diagnosis prior to either neoadjuvant treatment or surgery and then during treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2029-01-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07332975
The ClinicalTrials.gov registry entry for NCT07332975 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07332975 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07332975 about?
NCT07332975 is a clinical study titled "ctDNA Positive Patients Diagnosed With cT1bN0 and cT1cN0 TNBC". This translational biomarker study will collect blood in patients Stage I triple negative breast cancer at diagnosis prior to either neoadjuvant treatment or surgery and then during treatment.
What is the current status of trial NCT07332975?
This trial is currently recruiting. The enrollment target is 77 participants. The study started on 2026-01-20. Estimated completion is 2029-01-20.
Who is sponsoring clinical trial NCT07332975?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.